JP2019509274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509274A5 JP2019509274A5 JP2018543668A JP2018543668A JP2019509274A5 JP 2019509274 A5 JP2019509274 A5 JP 2019509274A5 JP 2018543668 A JP2018543668 A JP 2018543668A JP 2018543668 A JP2018543668 A JP 2018543668A JP 2019509274 A5 JP2019509274 A5 JP 2019509274A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidine
- carbonyl
- carbonitrile
- optionally substituted
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1602854.0A GB201602854D0 (en) | 2016-02-18 | 2016-02-18 | Novel compounds |
| GB1602854.0 | 2016-02-18 | ||
| PCT/GB2017/050403 WO2017141036A1 (en) | 2016-02-18 | 2017-02-16 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509274A JP2019509274A (ja) | 2019-04-04 |
| JP2019509274A5 true JP2019509274A5 (https=) | 2020-03-26 |
| JP6916197B2 JP6916197B2 (ja) | 2021-08-11 |
Family
ID=55752852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543668A Active JP6916197B2 (ja) | 2016-02-18 | 2017-02-16 | 新規化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10640498B2 (https=) |
| EP (1) | EP3416960B1 (https=) |
| JP (1) | JP6916197B2 (https=) |
| CN (1) | CN108699035B (https=) |
| GB (1) | GB201602854D0 (https=) |
| MA (1) | MA44233A (https=) |
| WO (1) | WO2017141036A1 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2976741C (en) * | 2015-03-30 | 2023-01-17 | Mission Therapeutics Limited | 1-cyano-pyrrolidine compounds as usp30 inhibitors |
| WO2017009650A1 (en) | 2015-07-14 | 2017-01-19 | Mission Therapeutics Limited | Cyanopyrrolidines as dub inhibitors for the treatment of cancer |
| GB201521109D0 (en) | 2015-11-30 | 2016-01-13 | Mission Therapeutics Ltd | Novel compounds |
| GB201522267D0 (en) * | 2015-12-17 | 2016-02-03 | Mission Therapeutics Ltd | Novel compounds |
| GB201522768D0 (en) | 2015-12-23 | 2016-02-03 | Mission Therapeutics Ltd | Novel compounds |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| GB201604638D0 (en) | 2016-03-18 | 2016-05-04 | Mission Therapeutics Ltd | Novel compounds |
| GB201604647D0 (en) | 2016-03-18 | 2016-05-04 | Mission Therapeutics Ltd | Novel compounds |
| CN108884068B (zh) | 2016-03-24 | 2021-02-26 | 特殊治疗有限公司 | 作为dub抑制剂的1-氰基-吡咯烷衍生物 |
| EP3512602B1 (en) | 2016-09-16 | 2024-03-27 | HSF Pharmaceuticals | Inhibitors of heat shock factors (hsf) and uses thereof |
| US11014912B2 (en) | 2016-09-27 | 2021-05-25 | Mission Therapeutics Limited | Cyanopyrrolidine derivatives with activity as inhibitors of USP30 |
| GB201616511D0 (en) | 2016-09-29 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
| GB201616627D0 (en) | 2016-09-30 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
| TWI771327B (zh) | 2016-10-05 | 2022-07-21 | 英商使命醫療公司 | 新穎化合物 |
| GB201708652D0 (en) | 2017-05-31 | 2017-07-12 | Mission Therapeutics Ltd | Novel compounds and uses |
| CN110831936B (zh) | 2017-06-20 | 2023-03-28 | 特殊治疗有限公司 | 具有dub抑制剂活性的取代氰基吡咯烷 |
| AU2018346597B2 (en) | 2017-10-06 | 2023-07-13 | Forma Therapeutics, Inc. | Inhibiting Ubiquitin Specific Peptidase 30 |
| US12522587B2 (en) | 2018-05-04 | 2026-01-13 | Remedy Plan, Inc. | Cancer treatments targeting cancer stem cells |
| JP7449242B2 (ja) | 2018-05-17 | 2024-03-13 | フォーマ セラピューティクス，インコーポレイテッド | ユビキチン特異的ペプチダーゼ３０（ｕｓｐ３０）阻害剤として有用な縮合二環化合物 |
| CN112384500B (zh) * | 2018-07-12 | 2024-05-14 | 贝达药业股份有限公司 | 免疫调节剂及其组合物和制备方法 |
| US11572374B2 (en) | 2018-08-14 | 2023-02-07 | Amgen Inc. | N-cyano-7-azanorbornane derivatives and uses thereof |
| JP7530889B2 (ja) * | 2018-10-05 | 2024-08-08 | フォーマ セラピューティクス，インコーポレイテッド | ユビキチン特異的プロテアーゼ３０（ｕｓｐ３０）阻害剤として作用する縮合ピロリン |
| CN120698983A (zh) | 2018-12-20 | 2025-09-26 | C4医药公司 | 靶向蛋白降解 |
| AU2019427489B2 (en) | 2019-01-28 | 2025-03-13 | Mitochondria Emotion, Inc. | Mitofusin activators and methods of use thereof |
| JP7734917B2 (ja) | 2019-01-28 | 2025-09-08 | ミトコンドリア エモーション， インク． | トランス－４－ヒドロキシシクロヘキシルフェニルアミドマイトフュージン活性化物質及びその使用方法 |
| CN109776377B (zh) * | 2019-02-01 | 2021-08-24 | 沈阳药科大学 | 吲哚啉类化合物及其制备方法和应用 |
| GB201905375D0 (en) | 2019-04-16 | 2019-05-29 | Mission Therapeutics Ltd | Novel compounds |
| GB201905371D0 (en) | 2019-04-16 | 2019-05-29 | Mission Therapeutics Ltd | Novel compounds |
| GB201912674D0 (en) | 2019-09-04 | 2019-10-16 | Mission Therapeutics Ltd | Novel compounds |
| EP4055008A1 (en) | 2019-11-06 | 2022-09-14 | Remedy Plan, Inc. | Cancer treatments targeting cancer stem cells |
| CA3170121A1 (en) * | 2020-02-05 | 2021-08-12 | The Rockefeller University | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
| JP2023520727A (ja) | 2020-04-08 | 2023-05-18 | ミッション セラピューティクス リミティド | Ｕｓｐ３０阻害剤として活性を有するｎ－シアノピロリジン |
| IL298526A (en) | 2020-05-28 | 2023-01-01 | Mission Therapeutics Ltd | N-(1-cyano-pyrrolidin-3-yl)-5-(3-(trifluoromethyl)phenyl)oxazole-2-carboxamide derivatives and the corresponding oxadiazole derivatives as usp30 inhibitors for the treatment of mitochondrial dysfunction |
| US20230303547A1 (en) | 2020-06-04 | 2023-09-28 | Mission Therapeutics Limited | N-cyanopyrrolidines with activity as usp30 inhibitors |
| DK4161929T3 (da) | 2020-06-08 | 2025-08-18 | Mission Therapeutics Ltd | 1-(5-(2-cyanopyridin-4-yl)oxazol-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyrrol-5(1h)-carbonitril som usp30-hæmmer til anvendelse i behandling af mitokondriedysfunktion, cancer og fibrose |
| GB202016800D0 (en) | 2020-10-22 | 2020-12-09 | Mission Therapeutics Ltd | Novel compounds |
| JP2024544660A (ja) | 2021-12-01 | 2024-12-03 | ミッション セラピューティクス リミティド | Ｕｓｐ３０阻害剤としての活性を有する置換ｎ－シアノピロリジン |
| TW202602454A (zh) * | 2024-04-15 | 2026-01-16 | 美商梅斯治療股份有限公司 | Ａｐｏｌ１抑制劑及其使用方法 |
| GB202408928D0 (en) | 2024-06-21 | 2024-08-07 | Mission Therapeutics Ltd | Novel compounds |
| GB202411060D0 (en) | 2024-07-29 | 2024-09-11 | Mission Therapeutics Ltd | Novel compounds |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1272467A4 (en) | 2000-04-06 | 2003-05-07 | Merck Frosst Canada Inc | Cathepsin cysteine protease inhibitors |
| EP2565186A1 (en) * | 2011-09-02 | 2013-03-06 | Hybrigenics S.A. | Selective and reversible inhibitors of ubiquitin specific protease 7 |
| GB201416754D0 (en) * | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
| CA2976741C (en) | 2015-03-30 | 2023-01-17 | Mission Therapeutics Limited | 1-cyano-pyrrolidine compounds as usp30 inhibitors |
| JP2018091344A (ja) * | 2015-03-31 | 2018-06-14 | 日立オートモティブシステムズ株式会社 | 鉄道車両用ダンパ |
| WO2017009650A1 (en) * | 2015-07-14 | 2017-01-19 | Mission Therapeutics Limited | Cyanopyrrolidines as dub inhibitors for the treatment of cancer |
| GB201521109D0 (en) | 2015-11-30 | 2016-01-13 | Mission Therapeutics Ltd | Novel compounds |
| GB201522267D0 (en) | 2015-12-17 | 2016-02-03 | Mission Therapeutics Ltd | Novel compounds |
| GB201522768D0 (en) | 2015-12-23 | 2016-02-03 | Mission Therapeutics Ltd | Novel compounds |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| GB201604647D0 (en) | 2016-03-18 | 2016-05-04 | Mission Therapeutics Ltd | Novel compounds |
| GB201604638D0 (en) | 2016-03-18 | 2016-05-04 | Mission Therapeutics Ltd | Novel compounds |
| CN108884068B (zh) | 2016-03-24 | 2021-02-26 | 特殊治疗有限公司 | 作为dub抑制剂的1-氰基-吡咯烷衍生物 |
| US11014912B2 (en) | 2016-09-27 | 2021-05-25 | Mission Therapeutics Limited | Cyanopyrrolidine derivatives with activity as inhibitors of USP30 |
| GB201616511D0 (en) | 2016-09-29 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
| GB201616627D0 (en) | 2016-09-30 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
| TWI771327B (zh) | 2016-10-05 | 2022-07-21 | 英商使命醫療公司 | 新穎化合物 |
-
2016
- 2016-02-18 GB GBGB1602854.0A patent/GB201602854D0/en not_active Ceased
-
2017
- 2017-02-16 WO PCT/GB2017/050403 patent/WO2017141036A1/en not_active Ceased
- 2017-02-16 EP EP17706864.0A patent/EP3416960B1/en active Active
- 2017-02-16 JP JP2018543668A patent/JP6916197B2/ja active Active
- 2017-02-16 MA MA044233A patent/MA44233A/fr unknown
- 2017-02-16 US US16/070,936 patent/US10640498B2/en active Active
- 2017-02-16 CN CN201780011427.3A patent/CN108699035B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509274A5 (https=) | ||
| JP7299837B2 (ja) | 化合物、組成物、および使用方法 | |
| JP6708661B2 (ja) | Ｕｓｐ３０阻害剤としての１−シアノ−ピロリジン化合物 | |
| EP3338781B1 (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
| NL1029016C2 (nl) | Tetrahydronafthyridinederivaten. | |
| JP2024508235A (ja) | 三環－アミド－二環ｐｒｍｔ５阻害剤 | |
| JP2019504009A5 (https=) | ||
| JP2019532945A5 (https=) | ||
| JP2019533659A5 (https=) | ||
| HK1250014A1 (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
| EP2958923A1 (de) | 4-substituierte pyrrolo- und pyrazolo-diazepine | |
| JP2018524367A5 (https=) | ||
| KR20150127197A (ko) | 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온 | |
| EP2958922A1 (de) | Pyrrolo- und pyrazolo-triazolodiazepine als bet-proteininhibitoren zur behandlung von hyper-proliferativen erkrankungen | |
| WO2014147586A1 (en) | 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh | |
| JP2011529504A5 (https=) | ||
| JP2009515883A (ja) | サイクリン依存性キナーゼ阻害剤としての新規イミダゾピラジン | |
| JP2013533868A (ja) | タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用 | |
| JP2012508702A (ja) | アミノアルキル置換基を有するアリール化合物およびそれらの使用 | |
| JP2019537590A5 (https=) | ||
| JP5847362B1 (ja) | シクロヘキシルピリジン誘導体 | |
| TW201217375A (en) | Diaza-spiro[5.5]undecanes | |
| US12344600B2 (en) | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | |
| CA2565689A1 (en) | Substituted pyrrolidine-2-ones | |
| US20220041606A1 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 |